Literature DB >> 21804673

Insomnia subtypes and their relationship to excessive daytime sleepiness in Brazilian community-dwelling older adults.

Cláudia Hara1, Robert Stewart, Maria Fernanda Lima-Costa, Fábio Lopes Rocha, Cíntia Fuzikawa, Elizabeth Uchoa, Josélia O A Firmo, Érico Castro-Costa.   

Abstract

STUDY
OBJECTIVES: To investigate the association between different types of insomnia as exposures and excessive daytime sleepiness (EDS) as a binary outcome in older Brazilian residents.
DESIGN: The baseline examination of the Bambuí Health and Ageing Study (BHAS), which is an ongoing population-based prospective cohort study of older adults.
SETTING: Bambuí (15,000 inhabitants), a city in the State of Minas Gerais, Southeast Brazil PARTICIPANTS: All residents aged ≥ 60 years were eligible to take part in the BHAS baseline. Of 1742 residents identified who were ≥ 60 years, 1606 (92.2%) were interviewed and received comprehensive examinations of health status.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: EDS was defined as the presence of sleepiness ≥ 3 times per week in the last month, causing any interference in usual activities. All insomnia subtypes were significantly associated with EDS in unadjusted analyses, and these associations were only modestly altered after adjusting incrementally for the other covariates. In a final model, the 3 insomnia subtypes were entered into a fully adjusted model simultaneously to investigate mutual independence, giving prevalence ratios of 1.63 (95% CI 1.14-2.31) for initial insomnia, 2.13 (95% CI 1.48-3.07) for middle insomnia, and 1.36 (95% CI 0.94-1.96) for terminal insomnia. The population attributable fractions for initial, middle, and terminal insomnia on prevalence of EDS were 17.6%, 32.9%, and 9.7%, respectively.
CONCLUSIONS: Middle insomnia emerged as the insomnia subtype most strongly associated with EDS. Further research is required to clarify causal pathways underlying this cross-sectional association.

Entities:  

Keywords:  Excessive daytime sleepiness; community; elderly; subtypes of insomnia

Mesh:

Year:  2011        PMID: 21804673      PMCID: PMC3138166          DOI: 10.5665/SLEEP.1172

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  37 in total

1.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

2.  The association of insomnia with anxiety disorders and depression: exploration of the direction of risk.

Authors:  Eric O Johnson; Thomas Roth; Naomi Breslau
Journal:  J Psychiatr Res       Date:  2006-09-15       Impact factor: 4.791

3.  Excessive daytime sleepiness in young adults: a 20-year prospective community study.

Authors:  Gregor Hasler; Daniel J Buysse; Alex Gamma; Vladeta Ajdacic; Dominique Eich; Wulf Rössler; Jules Angst
Journal:  J Clin Psychiatry       Date:  2005-04       Impact factor: 4.384

4.  Dimensions underlying the mini-mental state examination in a sample with low-education levels: the Bambuí health and aging study.

Authors:  Erico Castro-Costa; Cintia Fuzikawa; Cleusa Ferri; Elizabeth Uchoa; Joselia Firmo; Maria Fernanda Lima-Costa; Michael E Dewey; Robert Stewart
Journal:  Am J Geriatr Psychiatry       Date:  2009-10       Impact factor: 4.105

5.  Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.

Authors:  A B Newman; C F Spiekerman; P Enright; D Lefkowitz; T Manolio; C F Reynolds; J Robbins
Journal:  J Am Geriatr Soc       Date:  2000-02       Impact factor: 5.562

6.  Prevalence and risk factors of insomnia in community-dwelling Chinese elderly: a Taiwanese urban area survey.

Authors:  Tung-Ping Su; Shuang-Ruang Huang; Pesus Chou
Journal:  Aust N Z J Psychiatry       Date:  2004-09       Impact factor: 5.744

7.  Daytime sleepiness in an adult, Finnish population.

Authors:  C Hublin; J Kaprio; M Partinen; K Heikkilä; M Koskenvuo
Journal:  J Intern Med       Date:  1996-05       Impact factor: 8.989

Review 8.  From wakefulness to excessive sleepiness: what we know and still need to know.

Authors:  Maurice Moyses Ohayon
Journal:  Sleep Med Rev       Date:  2008-04       Impact factor: 11.609

9.  Determinants of excessive daytime sleepiness in a French community-dwelling elderly population.

Authors:  Norifumi Tsuno; Isabelle Jaussent; Yves Dauvilliers; Jacques Touchon; Karen Ritchie; Alain Besset
Journal:  J Sleep Res       Date:  2007-12       Impact factor: 3.981

10.  Insomnia: prevalence and its impact on excessive daytime sleepiness and psychological well-being in the adult Taiwanese population.

Authors:  Ching-Chiu Kao; Chun-Jen Huang; Mei-Yeh Wang; Pei-Shan Tsai
Journal:  Qual Life Res       Date:  2008-08-28       Impact factor: 4.147

View more
  4 in total

1.  Characterization of Patients Who Present With Insomnia: Is There Room for a Symptom Cluster-Based Approach?

Authors:  Megan R Crawford; Diana A Chirinos; Toni Iurcotta; Jack D Edinger; James K Wyatt; Rachel Manber; Jason C Ong
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

2.  Middle-of-the-night hypnotic use in a large national health plan.

Authors:  Thomas Roth; Patricia Berglund; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; Ronald C Kessler
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

3.  Leisure-Time Physical Activity and Sedentary Behavior and Their Cross-Sectional Associations with Excessive Daytime Sleepiness in the French SU.VI.MAX-2 Study.

Authors:  Roland M Andrianasolo; Mehdi Menai; Pilar Galan; Serge Hercberg; Jean-Michel Oppert; Emmanuelle Kesse-Guyot; Valentina A Andreeva
Journal:  Int J Behav Med       Date:  2016-04

4.  Gender differences influence over insomnia in Korean population: A cross-sectional study.

Authors:  Yun Kyung La; Yun Ho Choi; Min Kyung Chu; Jung Mo Nam; Young-Chul Choi; Won-Joo Kim
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.